Publication Records

THALEROVÁ, Sandra, Andrea VÍTEČKOVÁ WÜNSCHOVÁ, Patrícia KITTOVÁ, Lucie VAŠÁTKOVÁ, Michaela PEŠKOVÁ, Ondřej VOLNÝ, Anna MAC GILLAVRY DANYLEVSKA, Jan VÍTEČEK, Lukáš KUBALA and Robert MIKULÍK. A collateral circulation in ischemic stroke accelerates recanalization due to lower clot compaction. PLOS ONE. SAN FRANCISCO: PUBLIC LIBRARY SCIENCE, 2024. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0314079.

ŠTIKA, Jiří, Michaela PEŠOVÁ, Kateřina STAŇO KOZUBÍK, Magdalena SKALNÍKOVÁ, Lenka DOSTÁLOVÁ, Tomas LOJA, Lenka RADOVÁ, Veronika PALUŠOVÁ, Kamila RÉBLOVÁ, Zuzana VRZALOVÁ, Ivona BLAHÁKOVÁ, Jakub TRIZULJAK, Stjepan ULDRIJAN, Jan BLATNÝ, Michal ŠMÍDA, Šárka POSPÍŠILOVÁ and Michael DOUBEK. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study. British journal of haematology. Hoboken: Wiley-Blackwell, 2024, 9 pp. ISSN 0007-1048. Available from: https://dx.doi.org/10.1111/bjh.19694.

VALČÍKOVÁ, Barbora, Natália VADOVIČOVÁ, Karolína SMOLKOVÁ, Magdaléna ZACPALOVÁ, Pavel KREJČÍ, Shannon LEE, Jens RAUCH, Walter KOLCH, von Kriegsheim ALEXANDER, Anna DOROTÍKOVÁ, Zdeněk ANDRYSÍK, Rachel VICHOVA, Ondřej VACEK, Karel SOUČEK and Stjepan ULDRIJAN. eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations. Proceedings of the National Academy of Sciences of the United States of America. WASHINGTON: National Academy of Sciences, 2024, vol. 121, No 44, p. 1-12. ISSN 0027-8424. Available from: https://dx.doi.org/10.1073/pnas.2321305121.

DAĎOVÁ, Petra, Antónia MIKULOVÁ, Radim JAROUŠEK, Michaela CHORVÁTOVÁ, Stjepan ULDRIJAN and Lukáš KUBALA. A forskolin-mediated increase in cAMP promotes T helper cell differentiation into the Th1 and Th2 subsets rather than into the Th17 subset. International Immunopharmacology. Elsevier, 2023, vol. 125, December, p. 1-15. ISSN 1567-5769. Available from: https://dx.doi.org/10.1016/j.intimp.2023.111166.

ULDRIJAN, Stjepan. Generation and validation of a high-throughput screening system for the identification of eIF4F inhibitors with anti-melanoma activity. Masarykova univerzita, 2023.

SLABÝ, Ondřej, Jiří ŠÁNA, Iva SLANINOVÁ, Kateřina CETKOVSKÁ, Stjepan ULDRIJAN, Lívia EISELLEOVÁ and Lenka BEŠŠE. Lékařská biologie I. Buněčná a molekulární biologie (Medical Biology. Cellular and molecular biology). 1. dotisk 1. Brno: Masarykova univerzita, 2023, 268 pp. ISBN 978-80-280-0060-8.

SLABÝ, Ondřej, Iva SLANINOVÁ, David ŠMAJS, Jiří ŠÁNA, Vladimír ROTREKL, Pavel KREJČÍ, Stjepan ULDRIJAN, Juraj BOSÁK, Kateřina SLABÁ and Sabina ŠEVČÍKOVÁ. Lékařská biologie II. Genetika a molekulární medicína (Medical Biology II. Genetics and molecular medicine). 1st ed. Brno: Masarykova univerzita, 2023, 227 pp. ISBN 978-80-280-0338-8.

NOVÁK, Jan, Martin HOŘÁK, Jana FIALOVÁ KUČEROVÁ, Jan KUČERA, Šárka JELÍNKOVÁ, Daniela KURUCZOVÁ, Vladimír ROTREKL, Jan KREJČÍ, Stjepan ULDRIJAN, Petr FOJTÍK, Barbora VALČÍKOVÁ, Marie TOMANDLOVÁ, Josef TOMANDL, Filip ZLÁMAL and Julie DOBROVOLNÁ. Plazmatické hladiny FSTL1 a FSLT5 predikují obnovu funkce levé komory u pacientů s nově zjištěnou dilatační kardiomyopatií (FSTL1/5 Plasmatic Levels Predict Left Ventricular Function Recovery in Recent-Onset Dilated Cardiomyopathy Patients). In 50. pracovní konference „Komise experimentální kardiologie“. 2023. ISBN 978-80-11-03840-3.

KULÍŠKOVÁ, Petra, Lucie VAŠÁTKOVÁ and Iva SLANINOVÁ. Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis. International Journal of Molecular Sciences. BASEL: MDPI, 2023, vol. 24, No 20, p. 1-16. ISSN 1661-6596. Available from: https://dx.doi.org/10.3390/ijms242015405.

ERGIR, Ece, la Cruz Jorge OLIVER-DE, Soraia FERNANDES, Marco CASSANI, Francesco NIRO, Daniel PEREIRA DE SOUSA, Jan VRBSKY, Vladimir VINARSKY, Ana Rubina PERESTRELO, Doriana DEBELLIS, Natália VADOVIČOVÁ, Stjepan ULDRIJAN, Francesca CAVALIERI, Stefania PAGLIARI, Heinz REDL, Peter ERTL and Giancarlo FORTE. Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture. Nature Scientific Reports. Berlin: NATURE RESEARCH, 2022, vol. 12, No 1, p. 1-21. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-022-22225-w.

KITTOVÁ, Patrícia, Sandra THALEROVÁ, Andrea VÍTEČKOVÁ WÜNSCHOVÁ, Lucie VAŠÁTKOVÁ, Michaela PEŠKOVÁ, Ondřej VOLNÝ, Anna MAC GILLAVRY DANYLEVSKA, Jan VÍTEČEK, Lukáš KUBALA and Robert MIKULÍK. Kolaterálna cirkulácia zlepšuje rekanalizáciu pôsobením alteplázy: in vitro štúdia (Collateral circulation accelerates recanalization using alteplase: an in vitro study). In 66. Studentská vědecká konference LF MU. 2022. ISBN 978-80-280-0163-6.

SLABÝ, Ondřej, Jiří ŠÁNA, Iva SLANINOVÁ, Kateřina CETKOVSKÁ, Stjepan ULDRIJAN, Lívia EISELLEOVÁ and Lenka BEŠŠE. Lékařská biologie I. Buněčná a molekulární biologie (Medical Biology. Cellular and molecular biology). 1st ed. Brno: Masarykova univerzita, 2022, 268 pp. ISBN 978-80-280-0060-8.

SLABÝ, Ondřej, Iva SLANINOVÁ, Jiří ŠÁNA, Kateřina CETKOVSKÁ, Stjepan ULDRIJAN, Lívia EISELLEOVÁ and Lenka BEŠŠE. Medical biology I. Cell and Molecular Biology (Lékařská biologie I. Buněčná a molekulární biologie). 1st ed. Brno: Masarykova univerzita, 2022. ISBN 978-80-280-0158-2.

CERMAK, Vladimir, Aneta SKARKOVA, Ladislav MERTA, Veronika KOLOMAZNIKOVA, Veronika PALUŠOVÁ, Stjepan ULDRIJAN, Daniel ROSEL and Jan BRABEK. RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment. Biomolecules. BASEL: MDPI, 2021, vol. 11, No 3, p. 1-13. ISSN 2218-273X. Available from: https://dx.doi.org/10.3390/biom11030449.

MARQUES, Sérgio Manuel, Lucie ŠUPOLÍKOVÁ, Lenka MOLČANOVÁ, Karel ŠMEJKAL, David BEDNÁŘ and Iva SLANINOVÁ. Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance. BIOMEDICINES. BASEL: MDPI, 2021, vol. 9, No 4, p. 1-22. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines9040357.

MRKVOVÁ, Zuzana, Stjepan ULDRIJAN, A. POMBINHO, P. BARTŮNĚK and Iva SLANINOVÁ. ALBENDAZOL A FENBENDAZOL SNIŽUJÍ EXPRESI MDM2 A MDMX A AKTIVUJÍ P53 V NÁDOROVÝCH LINIÍCH SE ZVÝŠENOU EXPRESÍ MDMX. In 11. PragueONCO. 2020. ISBN 978-80-87339-61-9.

ŠTĚTKOVÁ, Monika, Kateřina GROWKOVÁ, Petr FOJTÍK, Barbora VALČÍKOVÁ, Veronika PALUŠOVÁ, Amandine VERLANDE, Radek JORDA, Vladimír KRYŠTOF, Václav HEJRET, Panagiotis ALEXIOU, Vladimír ROTREKL and Stjepan ULDRIJAN. CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells. CELL DEATH & DISEASE. LONDON: NATURE PUBLISHING GROUP, 2020, vol. 11, No 9, p. 1-14. ISSN 2041-4889. Available from: https://dx.doi.org/10.1038/s41419-020-02971-3.

PALUŠOVÁ, Veronika, Tereza RENZOVÁ, Amandine VERLANDE, Tereza VACLOVÁ, Michaela MEDKOVÁ, Linda CETLOVÁ, Miroslava SEDLÁČKOVÁ, Hana HŘÍBKOVÁ, Iva SLANINOVÁ, Miriama KRUTÁ, Vladimír ROTREKL, Hana UHLIROVA, Aneta KRIZOVA, Radim CHMELIK, Pavel VESELY, Michaela KRAFČÍKOVÁ, Lukáš TRANTÍREK, Kay Oliver SCHINK and Stjepan ULDRIJAN. Dual Targeting of BRAF and mTOR Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds. Cancers. BASEL: MDPI, 2020, vol. 12, No 6, p. 1-24. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers12061516.

KOSZTYU, Pavlína, Iva SLANINOVÁ, Barbora VALČÍKOVÁ, Amandine VERLANDE, Petr MÜLLER, Jan PALEČEK and Stjepan ULDRIJAN. A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize. Frontiers in Physiology. Lausanne: Frontiers Media, 2019, vol. 10, APR 9 2019, p. 1-14. ISSN 1664-042X. Available from: https://dx.doi.org/10.3389/fphys.2019.00390.

MRKVOVÁ, Zuzana, Stjepan ULDRIJAN, A. POMBINHO, P. BARTŮNĚK and Iva SLANINOVÁ. BENZIMIDAZOLES DOWNREGULATE MDM2 AND MDMX AND ACTIVATE P53 IN MDMX OVEREXPRESSING TUMOR CELL. In XXIII. Biologické dny. 2019. ISBN 978-80-270-6488-5.

MRKVOVÁ, Zuzana, Stjepan ULDRIJAN, Antonio POMBINHO, Petr BARTUNEK and Iva SLANINOVÁ. Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells. Molecules. BASEL: Mayer und Muller, 2019, vol. 24, No 11, p. 1-14. ISSN 1420-3049. Available from: https://dx.doi.org/10.3390/molecules24112152.

NĚMEC, Václav, Michaela HYLSOVÁ, Lukáš MAIER, Jana FLEGEL, Sonja SIEVERS, Slava ZIEGLER, Martin SCHRÖDER, Benedict-Tilman BERGER, Apirat CHAIKUAD, Barbora VALČÍKOVÁ, Stjepan ULDRIJAN, Stanislav DRÁPELA, Karel SOUČEK, Hebert WALDMANN, Stefan KNAPP and Kamil PARUCH. Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway. Angewandte Chemie International Edition. Weinheim: Wiley-VCH, 2019, vol. 58, No 4, p. 1062-1066. ISSN 1433-7851. Available from: https://dx.doi.org/10.1002/anie.201810312.

LO RE, Oriana, C. FUSILLI, F. RAPPA, M. VAN HAELE, J. DOUET, J. PINDJAKOVA, S.W. ROCHA, I. PATA, Barbora VALČÍKOVÁ, Stjepan ULDRIJAN, R.S. YEUNG, C.A. PEIXOTO, T. ROSKAMS, M. BUSCHBECK, T. MAZZA and M. VINCIGUERRA. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma. Hepatology. Philadelphia: Saunders, 2018, vol. 67, No 2, p. 636-650. ISSN 0270-9139. Available from: https://dx.doi.org/10.1002/hep.29519.

VERLANDE, Amandine, Michaela KRAFČÍKOVÁ, David POTĚŠIL, Lukáš TRANTÍREK, Zbyněk ZDRÁHAL, M. ELKALAF, J. TRNKA, Karel SOUČEK, N. RAUCH, J. RAUCH, W. KOLCH and Stjepan ULDRIJAN. Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization. EMBO reports. Hoboken: Wiley-Blackwell, 2018, vol. 19, No 2, p. 320-336. ISSN 1469-221X. Available from: https://dx.doi.org/10.15252/embr.201744524.

VALIANATOS, Georgios, Barbora VALČÍKOVÁ, Kateřina GROWKOVÁ, Amandine VERLANDE, Jitka VAŇÁČKOVÁ, Lenka RADOVÁ, Monika ŠTĚTKOVÁ, Michaela VYHŇÁKOVÁ, Ondřej SLABÝ and Stjepan ULDRIJAN. A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. Plos one. San Francisco: Public Library of Science, 2017, vol. 12, No 10, p. 1-18. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0185801.

GUDERNOVÁ, Iva, Lukáš BÁLEK, Miroslav VAŘECHA, Jana FIALOVÁ KUČEROVÁ, Michaela BOSÁKOVÁ, Bohumil FAFÍLEK, Veronika PALUŠOVÁ, Stjepan ULDRIJAN, Lukáš TRANTÍREK and Pavel KREJČÍ. Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480. Oncotarget. New York: Impact Journals LLC, 2017, vol. 8, No 65, p. 109319-109331. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.22674.

CETKOVSKÁ, Kateřina, Hana ŠUSTOVÁ and Stjepan ULDRIJAN. Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels independent of its deubiquitinase activity. Scientific Reports. LONDON: NATURE PUBLISHING GROUP, 2017, vol. 7, FEB 24 2017, p. 1-9. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/srep43180.

PÁCHNIKOVÁ, Gabriela, Stjepan ULDRIJAN, Aleš IMRAMOVSKÝ, Vladimír KRYŠTOF and Iva SLANINOVÁ. Substituted 2-hydroxy-N-(arylalkyl)benzamide sensitizes cancer cells to metabolic stress by disrupting actin cytoskeleton and inhibiting autophagic flux. Toxicology in Vitro. Kidlington: Pergamon-Elsevier Science LTD, 2016, vol. 37, "neuvedeno", p. 70-78. ISSN 0887-2333. Available from: https://dx.doi.org/10.1016/j.tiv.2016.09.006.

CETKOVSKÁ, Kateřina, Hana ŠUSTOVÁ, Pavlína KOSZTYU and Stjepan ULDRIJAN. A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity. Plos one. San Francisco: Public Library of Science, 2015, vol. 10, No 12, p. 1-19. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0144753.

VONDROVÁ, Lucie, Lucie KOZÁKOVÁ, Karel STEJSKAL, Panagoula CHARALABOUS, Peter KOLESÁR, Alan LEHMANN, Stjepan ULDRIJAN, Christopher M. SANDERSON, Zbyněk ZDRÁHAL and Jan PALEČEK. Evolution of the NSE1-NSE3-NSE4 subcomplex of the human SMC5/6 complex. In SMC proteins: Chromosomal organizers from bacteria to human. 2015.

KOZÁKOVÁ, Lucie, Lucie VONDROVÁ, Karel STEJSKAL, Panagoula CHARALABOUS, Peter KOLESÁR, Alan R. LEHMANN, Stjepan ULDRIJAN, Christopher M. SANDERSON, Zbyněk ZDRÁHAL and Jan PALEČEK. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex. Cell Cycle. Philadelphia: Taylor&Francis Inc, 2015, vol. 14, No 6, p. 920-930. ISSN 1538-4101. Available from: https://dx.doi.org/10.1080/15384101.2014.1000112.

VALIANATOS, Georgios, Vladimír PEKAŘÍK and Stjepan ULDRIJAN. Epigenetické reprogramování buněk vybraných neuroektodermálních nádorů. In XXI. Biologické dny : Pokroky a výzvy současné nádorové biologie. 2014. ISBN 978-80-260-6793-1.

VERLANDE, Amandine, Michaela KRAFČÍKOVÁ, Lukáš TRANTÍREK, I JELÍNKOVÁ, Alena HYRŠLOVÁ VACULOVÁ and Stjepan ULDRIJAN. Modulation of melanoma metabolism and viability with hexokinase and mitochondrial complex I inhibitors. In EMBO conference: Cellular signaling and cancer therapy, Hotel Croatia, Cavtat, Croatia, May 23-27, 2014, poster presentation. 2014.

VERLANDE, Amandine and Stjepan ULDRIJAN. Combination of mitochondrial oxidative phosphorylation and hexokinase inhibitors activates pro-survival pathways in melanoma. In Cancer and Metabolism 2013, De Rode Hoed, Amsterdam, The Netherlands, June 24-25, 2013, poster presentation. 2013.

USTIANENKO, Dmytro, Dominika HROŠŠOVÁ, David POTĚŠIL, Kateřina CHALUPNÍKOVÁ, Kristýna HRAZDILOVÁ, Jiří PACHERNÍK, Kateřina CETKOVSKÁ, Stjepan ULDRIJAN, Zbyněk ZDRÁHAL and Štěpánka VAŇÁČOVÁ. Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs. RNA. New York: Cold Spring Harbor Laboratory Press, 2013, vol. 19, No 12, p. 1632-1638. ISSN 1355-8382. Available from: https://dx.doi.org/10.1261/rna.040055.113.

CETKOVSKÁ, Kateřina, Hana ŠUSTOVÁ and Stjepan ULDRIJAN. Function analysis of newly identified regulator of the MDM2-P53 pathway. In Mechanisms&Models of Cancer, 14.-18.8.2012, Cold Spring Harbor Laboratory, New York, USA. 2012.

DOLEŽELOVÁ, Pavlína, Iva SLANINOVÁ, Karen VOUSDEN and Stjepan ULDRIJAN. Identification of differences in the primary structure of MDM2 and MDMX ring domains that render MDMX inactive. In Mechanisms & Models of Cancer, 14.-18.8.2012, Cold Spring Harbor Laboratory, New York, USA. 2012.

ROTREKL, Vladimír, Miriama KRUTÁ, Kateřina SCHRAMMOVÁ, Stjepan ULDRIJAN, Sergiy KYRYLENKO and Petr DVOŘÁK. Metabolic changes in human embryonic stem cells are regulated by FGF2. In ISSCR 10th Annual Meeting, 13.-.16.6.2012, Yokohama, Japonsko. 2012.

DOLEŽELOVÁ, Pavlína, Kateřina CETKOVSKÁ, Karen H. VOUSDEN and Stjepan ULDRIJAN. Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers. Cell Cycle. 2012, vol. 11, No 5, p. 953-962. ISSN 1538-4101. Available from: https://dx.doi.org/10.4161/cc.11.5.19445.

KOSZTYU, Pavlína, Kateřina CETKOVSKÁ, Karen H. VOUSDEN and Stjepan ULDRIJAN. Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability. FEBS Letters. Netherlands: ELSEVIER SCIENCE BV, 2012, vol. 586, No 16, p. 2225-2231. ISSN 0014-5793. Available from: https://dx.doi.org/10.1016/j.febslet.2012.05.034.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ, Alena HYRŠLOVÁ VACULOVÁ and Iva SLANINOVÁ. Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine. Biological Chemistry. Berlin, DE: Walter de Gruyter&CO, 2012, vol. 393, No 7, p. 647-658. ISSN 1431-6730. Available from: https://dx.doi.org/10.1515/hsz-2011-0279.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Lucia KNOPFOVÁ, Iva SLANINOVÁ and Stjepan ULDRIJAN. P38 MAPK inhibitors cooperates with endoplasmic reticulum stress-inducing agents to promote apoptosis and modulate ERK pathway activity in melanoma cells. In Mechanisms & Models of Cancer, 14.-18.8.2012, Cold Spring Harbor Laboratory, New York, USA. 2012.

VERLANDE, Amandine and Stjepan ULDRIJAN. Salicylate and aspirin combined with PI3Ks inhibitor LY294002 or with natural pro-aptotic agent gossypol promote melanoma cell death. In Natural Anticancer Drugs, 30.6.-4.7.2012, Olomouc, Biomed Pap Med Fac Univ Palacky Olomouc Czech Republ. 2012 Jun; 156 (Supplement 1):S1-S100. 2012. ISSN 1213-8118.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ, Alena HYRŠLOVÁ and Iva SLANINOVÁ. Sanguilutine induces caspase-independent type of cell death modulated by autophagy. In Mechanisms & Models of Cancer, 14.-18.8.2012, Cold Spring Harbor Laboratory, New York, USA. 2012.

VERLANDE, Amandine and Stjepan ULDRIJAN. The glycolysis inhibitor 2-deoxy-D-glucose prmotes survival of melanoma cells through the activation of the adenylate cyclase/camp/PKA pathway. In Mechanisms & Models of Cancer, 14.-18.8.2012, Cold Spring Harbor Laboratory, New York, USA. 2012. 2012.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine alkaloids - compounds with high anti-proliferative activity against malignant melanoma. In European Multidisciplinary Cancer Congress, Stockholm, Sweden, 23.-27.9.2011. 2011.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine alkaloids - compounds with high anti-proliferative activity against malignant melanoma. In FEBS-EACR Advanced Lecture Course, 16-24.8.2011, Spetses, Greece. 2011.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine alkaloids - compounds with high anti-proliferative activity against malignant melanoma. In In ISCEC, 7.-.10.9.2011, Lausanne, Switzerland. 2011.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine Alkaloids - Compounds With High Anti-proliferative Activity Against Malignant Melanoma. In European Multidisciplinary Cancer Congress, Stockholm, Sweden, 23.-27.9.2011; European Journal of Cancer. 2011.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. Journal of Dermatological Science. 2011, vol. 62, No 1, p. 22-35. ISSN 0923-1811. Available from: https://dx.doi.org/10.1016/j.jdermsci.2011.01.006.

HAMMEROVÁ, Jindřiška, Stjepan ULDRIJAN, Olga KRUPKOVÁ, Eva TÁBORSKÁ and Iva SLANINOVÁ. Benzo[c]phenanthridine alkaloids induce various types of cell death in cancer cells. In The Student Scientific Conference on Cancer Research, Brno, 7.-8.4.2011. 2011.

SLANINOVÁ, iva, Jindřiška HAMMEROVÁ, Stjepan ULDRIJAN and Eva TÁBORSKÁ. Benzo[c]phenanthridine Alkaloids Induce Various Types of the Cell Death in Melanoma Cells. In Book of Abstracts of Analytical Cytometry VI. Praha 8.-11.10.2011. 2011.

KRUTÁ, Miriama, Kateřina SCHRAMMOVÁ, Stjepan ULDRIJAN, Miroslava NEHYBOVÁ, Sergiy KYRYLENKO, Petr DVOŘÁK and Vladimír ROTREKL. FGF2 regulates the response of human embryonic stem cells to changes in metabolism. In XV. Setkání biochemiků a molekulárních biologů, Brno, 1.-2.11.2011. 2011.

CETKOVSKÁ, Kateřina and Stjepan ULDRIJAN. Function analysis of newly identified regulator of oncoprotein Mdm2. In FEBS-EACR Advanced Lecture Course, 16-24.8.2011, Spetses, Greece. 2011.

CETKOVSKÁ, Kateřina and Stjepan ULDRIJAN. Function analysis of newly identified regulator of oncoprotein Mdm2. In ISCEC, 7.-.10.9.2011, Lausanne, Switzerland. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. Functional analysis of Mdm2 suggests differences between Mdm2 homodimers and Mdm2/MdmX heterodimers. In XX. Biologické dny, Plzeň, 25.-.27.10.2011. 2011. 2011.

CETKOVSKÁ, Kateřina and Stjepan ULDRIJAN. Identifikace a funkční analýza nového regulátoru onkoproteinu Mdm2. In Genetická konference, Lednice, 14.-16.9. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Tereza VACLOVÁ and Stjepan ULDRIJAN. Kombinace SB202190 a gossypolu významně snižuje viabilitu buněk maligního melanomu. In Lednice, 14.-16.9.2011. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Petr BABULA and Stjepan ULDRIJAN. Potenciál kombinace negenotoxických látek SB202190 a gossypolu v cílené terapii maligního melanomu. In Chemické listy, vol. 105 (5) 321-436 ISSN 0009-2770. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Tereza VACLOVÁ and Stjepan ULDRIJAN. p38 MAPK - a potential target for metastatic melanoma therapy? In FEBS-EACR Advanced Lecture Course, 16-24.8.2011, Spetses, Greece. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Tereza VACLOVÁ and Stjepan ULDRIJAN. p38 MAPK - a potential target for metastatic melanoma therapy? In ISCEC, 7.-.10.9.2011, Lausanne, Switzerland. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Tereza VACLOVÁ and Stjepan ULDRIJAN. P38 MAPK - a Potential Target for Metastatic Melanoma Therapy? In European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care. 2011. ISSN 0959-8049.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Tereza VACLOVÁ and Stjepan ULDRIJAN. p38 MAPK - a promising target for metastatic melanoma therapy? In The Student Scientific Conference on Cancer Research, Brno, 7.-8.4.2011. 2011.

KRUPKOVÁ, Olga, Jindřiška HAMMEROVÁ, Petr BABULA and Stjepan ULDRIJAN. Role autofagie v cílené léčbě maligního melanomu. In XXXV. Brněnské onkologické dny a XXV. Konference pro nelékařské zdravotnické pracovníky, Brno, 21.-23.4.2011. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. Studium vlivu délky C-koncové části onkoproteinu Mdm2 na jeho aktivitu vůči nádorovému supresoru p53. In Genetická konference, Lednice, 14.-16.9.2011. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. The conserved length of the C-terminal tail is essential for the activitiy of Mdm2 RING towards p53. In FEBS-EACR Advanced Lecture Course, 16-24.8.2011, Spetses, Greece. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. The conserved length of the C-terminal tail is essential for the activity of Mdm2 RING towards p53. In European Multidisciplinary Cancer Congress, Stockholm, Sweden, 23.-27.9.2011. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. The conserved length of the C-terminal tail is essential for the activity of Mdm2 RING towards p53. In ISCEC, 7.-.10.9.2011, Lausanne, Switzerland. 2011.

DOLEŽELOVÁ, Pavlína and Stjepan ULDRIJAN. The length of the extreme C-terminal tail of Mdm2 is critical for its activity towards p53. In The Student Scientific Conference on Cancer Research, Brno, 7.-8.4.2011. 2011.

KRUTÁ, Miriama, Stjepan ULDRIJAN, Kateřina SCHRAMMOVÁ, Lukáš BÁLEK, Renata HEJNOVÁ, Šárka JELÍNKOVÁ, Sergiy KYRYLENKO, Petr DVOŘÁK and Vladimír ROTREKL. The two faces of FGF2 in metabolic pathway regulation in hESCs. In XX. Biologické dny, Plzeň, 25.-.27.10.2011. 2011.

ORALOVÁ, Veronika and Stjepan ULDRIJAN. Therapeutic potential of CDK inhibitor roscovitine in malignant melanoma. In The Student Scientific Conference on Cancer Research, Brno, 7.-8.4.2011. 2011.

KRYŠTOF, Vladimír and Stjepan ULDRIJAN. Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs. Current Drug Targets. 2010, vol. 11, No 3, p. 291-302. ISSN 1389-4501.

CETKOVSKÁ, Kateřina and Stjepan ULDRIJAN. Function analysis of two newly identified Mdm2-interacting proteins in cellular stress response pathways. In The student scientific conference on genetically modified organisms, Brno 8-9.4.2010. 2010. ISBN 978-80-210-5160-7.

DOLEŽELOVÁ, Pavlína, Kateřina CETKOVSKÁ and Stjepan ULDRIJAN. Funkční analýza RING domén onkoproteinů mdm2 a MdmX (Functional analysis of RING domains of oncoproteins Mdm2 and MdmX). In X. MEZIOBOROVÉ SETKÁNÍ MLADÝCH BIOLOGŮ, BIOCHEMIKŮ A CHEMIKŮ pořádané firmou Sigma-Aldrich, 25.5. – 28.5. 2010, Devět skal – Žďárské vrchy. 2010. ISSN 1213-7103.

ULDRIJAN, Stjepan, Kateřina CETKOVSKÁ and Karen H. VOUSDEN. Identification and analysis of novel Mdm2/MdmX-interacting proteins involved in the regulation of the p53 tumour suppressor pathway. In The Multiple Tiers of Gene Regulation in Cancer, Scotland, Glasgow, 4-7.7.2010. 2010.

CETKOVSKÁ, Kateřina, Stjepan ULDRIJAN and Karen H. VOUSDEN. Identification and analysis of two novel Mdm2-interacting proteins involved in the regulation of cellular stress response pathways. In 21st meeting of the European Associaton for Cancer Research, Norway, Oslo, 26-29.7.2010. 2010. ISSN 1359-6349.

CETKOVSKÁ, Kateřina, Karen VOUSDEN and Stjepan ULDRIJAN. Identifikace nových vazebných partnerů pro onkoprotein Mdm2 a jejich vliv na regulaci Mdm2 a p53 v nádorových buňkách (Identification of novel binding partners for oncoprotein Mdm2 and their influence on the regulation of Mdm2 and p53 in cancer cells). In X. MEZIOBOROVÉ SETKÁNÍ MLADÝCH BIOLOGŮ, BIOCHEMIKŮ A CHEMIKŮ pořádané firmou Sigma-Aldrich, 25.5. – 28.5. 2010, Devět skal – Žďárské vrchy. 2010. ISSN 1213-7103.

DOLEŽELOVÁ, Pavlína, Stjepan ULDRIJAN and Iva SLANINOVÁ. Insight into the structural and functional differences of Mdm2 and MdmX RING finger domains. In The student scientific conference on genetically modified organisms, Brno 8-9.4.2010. 2010. ISBN 978-80-210-5160-7.

MORAVCOVÁ, Daniela, Libor HAVLÍČEK, Vladimír KRYŠTOF, René LENOBEL, Pavla BINAROVÁ, Petr MLEJNEK, Bořek VOJTĚŠEK, Stjepan ULDRIJAN, Thomas SCHMÜLLING and Miroslav STRNAD. Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use. 2010.

ULDRIJAN, Stjepan, Tereza VACLOVÁ, Veronika ORALOVÁ, Jindřiška HAMMEROVÁ, Miroslava SEDLÁČKOVÁ, Hana HŘÍBKOVÁ, Kateřina CETKOVSKÁ and Iva SLANINOVÁ. Small molecule inhibitors of cellular stress response pathways can modulate viability of malignant melanoma cells. In 21st meeting of the European Associaton for Cancer Research, Norway, Oslo, 26-29.7.2010. 2010. ISSN 1359-6349.

ULDRIJAN, Stjepan, Kateřina CETKOVSKÁ and Karen VOUSDEN. Analysis of Mdm2 domains involved in p53 degradation. In International MDM2 Workshop V. Ghent, Belgium: University of Ghent, 2009, 1 pp.

HROŠŠOVÁ, Dominika, Stjepan ULDRIJAN, Aleš HAMPL, Zbyněk ZDRÁHAL and Štěpánka VAŇÁČOVÁ. Characterization of a specific 3'- end RNA modification and specific RNA- binding proteins. In RNA Club 2009. 2009. ISSN 1214-8598.

CETKOVSKÁ, Kateřina, Stjepan ULDRIJAN and Vousden KAREN. Identification and functional analysis of novel binding partners for oncoprotein Mdm2. In 1st International Student Medical Congress Košice. 2009. ISBN 978-80-7097-759-0.

CETKOVSKÁ, Kateřina, Stjepan ULDRIJAN and Karen VOUSDEN. Identification and functional analysis of novel binding partners for oncoprotein Mdm2. In XIII. Setkání biochemiků a molekulárních biologů. Sborník příspěvků. Brno: Masarykova univerzita, 2009, 1 pp. ISBN 978-80-210-4830-0.

ULDRIJAN, Stjepan, Kateřina CETKOVSKÁ, Lucie BAČÁKOVÁ and Karen VOUSDEN. Oncoproteins Mdm2 and MdmX: Their roles in the regulation of the p53 tumour suppressor protein. In XIII. Setkání biochemiků a molekulárních biologů. Sborník příspěvků. Brno: Masarykova univerzita, 2009. ISBN 978-80-210-4830-0.

CETKOVSKÁ, Kateřina, Karen VOUSDEN and Stjepan ULDRIJAN. Regulation of cellular stress response pathways by interactions between Mdm2 and transcription factor GTF2I. In International MDM2 Workshop V. Ghent, Belgium, 2009, 1 pp.

ULDRIJAN, Stjepan and Karen H. VOUSDEN. Regulation of the P53 tumour suppressor protein by MDM2 and MDMX. In XII. Setkání biochemiků a molekulárních biologů 5.-6. února 2008 Brno. 2008. ISBN 978-80-210-4526-2.

ULDRIJAN, Stjepan, Willem-Jan PANNEKOEK and Karen H. VOUSDEN. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. EMBO Journal. 2007, vol. 26, No 1, p. 102-120. ISSN 0261-4189.

ULDRIJAN, Stjepan and Karen VOUSDEN. Analysis of MDM2 and MDMX domains involved in p53 ubiquitylation and degradation (Analysis of MDM2 and MDMX domains involved in p53 ubiquitylation and degradation; Oncogenes and Human Cancer). In Oncogenes and Human Cancer: The next 25 Years. Madrid, Spain, October 3-6, 2007.